Physician

Adrian Michael Pristas, M.D.

According to 2025 Medicare claims, Adrian Pristas, M.D. (NPI: 1821088592) practices pulmonary disease in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 07730-1700.

Pristas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 887 traditional Medicare patients, billed 1,458 HCPCS/CPT codes, and received $147,391 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,878 prescription claims across 619 beneficiaries totaling $1,841,412 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 5,783 claims. Open Payments data shows 102 records totaling $2,204. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $278,114 to $147,391. In contrast, Part D prescription costs have risen steadily, from $749,583 to $1,841,412. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	886	4,233	$278,114
2016	944	3,479	$269,247
2017	858	2,674	$205,379
2018	872	2,436	$194,172
2019	967	2,888	$235,509
2020	908	2,259	$184,289
2021	1,013	2,521	$242,744
2022	1,028	2,296	$207,852
2023	889	1,533	$167,051
2024	887	1,458	$147,391

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	289	2,215	$749,583
2016	340	2,579	$1,476,525
2017	390	2,669	$1,248,507
2018	407	2,817	$1,296,117
2019	444	3,078	$1,447,715
2020	460	3,320	$1,439,239
2021	457	2,829	$1,518,087
2022	476	2,459	$1,376,545
2023	589	3,197	$1,546,932
2024	619	3,878	$1,841,412

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,010	3,513	$216,936
2016	1,105	3,457	$176,298
2017	1,221	3,512	$172,023
2018	1,471	4,091	$172,082
2019	1,786	4,912	$280,760
2020	1,740	5,065	$335,199
2021	1,623	4,673	$324,402
2022	1,618	4,329	$287,589
2023	1,932	5,320	$350,259
2024	2,240	5,783	$347,318

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	161	161	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	721	1,131	$105
95810	Sleep study in sleep lab (6 years or older)	26	26	$101
95800	Sleep study including heart rate, breathing, and sleep time	64	65	$33
94010	Test to measure expiratory airflow and volume	35	35	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	766	29,585	$606,707
Ofev	Nintedanib Esylate	15	450	$195,968
Opsumit	Macitentan	11	330	$141,198
Esbriet	Pirfenidone	12	360	$125,048
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	205	8,160	$117,698

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	15	97	$73,772
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	50	$44,087
E0601	Continuous positive airway pressure (cpap) device	Y	141	827	$22,834
A7030	Full face mask used with positive airway pressure device, each	N	136	283	$21,445
A7031	Face mask interface, replacement for full face mask, each	N	118	251	$21,299

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	102	$2,204	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adrian Michael Pristas, M.D.?

Tedicare shows public-source Medicare data for Adrian Michael Pristas, M.D. (NPI 1821088592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Michael Pristas, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adrian Michael Pristas, M.D.?

Adrian Michael Pristas, M.D. is linked to HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (billing NPI 1215989249) in the available physician profile data.

Does Adrian Michael Pristas, M.D. have Open Payments data?

Adrian Michael Pristas, M.D. has 102 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.